Vaccine Info

Measles Vaccines 2023

Authored by
Last reviewed
January 25, 2023
Fact checked by
Robert Carlson, MD

Measles Vaccines 2023

Measles vaccination programs started in 1963 and will continue in 2023. As of February 2022, the U.S. Centers for Disease Control and Prevention (CDC) published the updated measles vaccination schedules for children, adults, and international travelers.

On February 23, 2022, the CDC's MMR Vaccine Work Group presented: Overview of Measles in the U.S. by Ms. Lynn Bahta, Work Group Chair, and Overview of GSK's MMR Vaccine by Remon Abu-Elyazeed, MD, Ph.D., US Vaccines Medical and Clinical Affairs. 

Measles Vaccines What's New

The U.S. Food and Drug Administration (FDA) recently approved the Priorix vaccine to prevent measles, mumps, and rubella (MMR) in individuals one year and older. The U.S. CDC stated on November 18, 2022, PRIORIX and M-M-R II are considered fully interchangeable, including for all off-label recommended uses. 

The CDC reported on January 13, 2023, nationally, 2-dose MMR coverage was 93.5% (range = 78.0% [Alaska] to 98.0% [New York]) during the 2020–21 school year.

Measles Vaccines - U.S. FDA Approved For 2023

M-M-R® II - The Measles, Mumps, and Rubella Virus Vaccine Live (M-M-R II) is approved by the U.S. FDA for use in people 12 months and older. Two doses of the MMR vaccine are about 97% effective at preventing measles, and one dose is about 93% effective.

Proquad - Children ages 1 through 12 may also get the Measles, Mumps, Rubella, and Varicella Virus Vaccine (MMRV). This FDA-approved vaccine also prevents chickenpox.

Priorix - Is licensed in the USA and over 100 countries for use in individuals aged 9 or 12 months, according to a 1- or 2-dose schedule, depending on the country. Priorix protects people against MMR. The CDC vaccine committee recommends PRIORIX according to the existing MMR vaccine schedules and off-label uses as an option to prevent MMR.

Measles Vaccines Globally Approved

Tresivac - This vaccine is available in India to prevent measles, mumps, and rubella. Serum Institute of India Ltd is the manufacturer.

Shanghai Institute of Biological Products, a subsidiary of China-based Sinopharm, released about 42 million MMR doses in China in 2020. 

Measles Vaccine Price

According to the U.S. CDC, measles vaccine prices range from $87.31 to $250.02 as of July 2022. Additional measles vaccine prices and discount information are posted at InstantRx™.

Measles Outbreaks

According to the CDC, the U.S. has maintained its measles-free elimination status for over twenty years. However, as of January 19, 2023, the CDC had confirmed (121) measles patients in six jurisdictions during 2022. In 2021, a total of 49 measles cases were reported by five jurisdictions. Other measles outbreak news is posted at this Vax-Before-Travel link.

Measles Vaccine News For 2022-2023

January 16, 2023 - Jefferson County Public Schools in western Kentucky held measles vaccination clinics at several schools for under-vaccinated students.

December 22, 2022 - The journal Nature published an article: Massive measles outbreak threatens India's goal to eliminate the disease by 2023.

November 23, 2022 - The WHO and the U.S. CDC reported declining global progress toward achieving and maintaining measles elimination.

November 18, 2022 - The CDC published MMWR: Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022.

November 17, 2022 - The Australian state of Victoria recorded three new measles cases in returned overseas travelers from Singapore. Australia's NSW Health confirmed the first local case of measles since February 2020 in September 2022.

November 9, 20, 2022 - Columbus Public Health and Franklin County Public Health recently verified four new measles cases, all in unvaccinated children with no travel history. Franklin County has confirmed eight cases since June 16, 2022.

October 25, 2022 - GAVI reported that in 2019, Papua New Guinea vaccinated 1.17 million children aged six months to five years against measles-rubella. The coverage data indicates that the number of children vaccinated exceeded the targeted 95% of the population.

October 17, 2022 - The World Health Organization and UNICEF welcomed funding agreements valued at US$ 10 million further to bolster polio and measles programs in eight countries.

September 29, 2022 - The UKHSA published Childhood Vaccination Coverage Statistics- England, 2021-22. MMR1 coverage at 24 months was 89.2% in 2021-22, a decrease from 90.3% in 2020-21, and MMR1 coverage at five years was 93.4% in 2021-22, a decrease from 94.3% the previous year.

September 21, 2022 - The Minnesota Health Department issued a Health Advisory: Tenth Travel-Associated Measles Case in June 2022.

September 13, 2022 - Australia's NSW Health confirmed the first case of measles since February 2020. This adult acquired the infection while traveling in Asia.

August 29, 2022 - The Tongogara Refugee Camp in Zimbabwe recorded 26 measles cases since the 2022 outbreak.

August 20, 2022 - Study: Vaccination Against Measles, Mumps, Rubella, and Incident Inflammatory Bowel Disease in a National Cohort of Privately Insured Children. Children who had received at least one dose of MMR had a lower risk for inflammatory bowel disease than children who did not (hazard ratio, 0.71; 95% confidence interval, 0.59-0.85). 

August 18, 2022 - Germany's Constitutional Court (Bundesverfassungsgericht) confirmed daycare facilities could require children to be vaccinated or be recovered (immunity) from measles before attending.

August 17, 2022 - The AP reported that 2,056 measles cases had been reported in Zimbabwe and 157 child fatalities.

August 12, 2022 - The ECDC's Communicable Disease Threats Report - between 12 July 2022 and 8 August, 12 new cases were reported by four countries in the EU/EEA: Germany (7), Hungary (2), Ireland (2) and Poland (1). And no measles-related deaths were reported in the EU/EEA in 2022.

August 5, 2022 - WHO's Pan American Health Organization report (Vol. 28, No. 30) ending 30 July 2022, 55 cases were reported in four countries: Brazil (44), the USA (6), Argentina (2), and Canada (3).

July 10, 2022 - Fiji's Measles Outbreak Spreads to Other Pacific Islands.

June 14, 2022 - The Minnesota Department of Health announced it is investigating two confirmed measles cases in unvaccinated children who are siblings in Hennepin County who recently traveled internationally. 

June 10, 2022 - Since the previous monthly measles update in ECDC's Communicable Disease Threats Report on May 20, 2022, seven countries have reported 18 new cases in the EU/EEA: Bulgaria (1), Germany (8), Hungary (1), Ireland (1), Poland (3), Romania (3) and Spain (1).

June 6, 2022 - The U.S. FDA approved Priorix for active immunization to prevent measles, mumps, and rubella in individuals 12 months and older.

April 27, 2022 - "Measles is more than a dangerous and potentially deadly disease. It is also an early indication that there are gaps in our global immunization coverage, gaps vulnerable children cannot afford," commented Catherine Russell, UNICEF Executive Director.

April 8, 2022 - The Republic of Congo has declared a measles epidemic. Pointe Noire and the district of Ntchamba-Nsassi in the south of the African country are among the most affected areas, with more than 3,400 cases, including 78 deaths, according to the Ministry of Health and Population. As a result, the Congolese government and the Global Alliance for Vaccines and Immunisation (GAVI) are preparing the roll-out of a vaccination campaign in May 2022.

April 6, 2022 - Research presented in Portugal (23-26 April) suggests that the current two-dose measles immunization target of 95% may be the minimum required to provide protective immunity to achieve and maintain measles elimination. Only six countries in the EU/EEG (Croatia, Hungary, Iceland, Portugal, Slovakia, and Sweden) report coverage of a two-dose measles vaccine of 95% or higher, suggesting that eliminating measles in the EU is uncertain.

March 30, 2022 - The BMJ published an Opinion article: We urgently need to increase MMR vaccine uptake. Even a slight decline in MMR vaccine uptake—the "canary in the coalmine"—can herald disease outbreaks. The latest U.K. data for July to September 2021 reported 88.6% uptake of the first dose of MMR at 24 months, with 85.5% uptake of two doses at five years—a decline from previous quarters.

March 20, 2022 - Nigeria, Pakistan, Somalia, and India reported the most measles cases in the second half of 2021.

March 17, 2022 - The U.S. CDC issued a Level 1 Travel Advisory stating: There is an outbreak of measles in Afghanistan. Cases have been reported in all provinces, with the highest rates occurring in Paktya, Balkh, Kunduz, Zabul, Kandahar, and Logar. Therefore, all travelers to Afghanistan, including infants and preschool-aged children, should be fully vaccinated.'

March 14, 2022 - UK media reported the new Omicron sub-variant deltacron is almost as infectious as measles.

March 14, 2022 - The WHO confirmed a measles vaccination campaign launched in Afghanistan; around 1.2 million children in 24 provinces got vaccinated.

March 8, 2022 - The ECDC reported measles is a serious concern in Ukraine, as the overall vaccination coverage for two doses of measles-containing vaccine (81.9% in 2020) is insufficient to prevent outbreaks.

March 4, 2022 - The U.S. CDC issued a Watch - Level 1, Practice Usual Precautions, regarding measles outbreaks in Africa.

February 11, 2022 - The U.S. CDC published 'Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination — Worldwide, 2012–2020.'

February 10, 2022 - The WHO confirmed Afghanistan officials reported 35,319 suspected cases from Jan 1, 2021, through Jan 29, 2022. Of those, 3,221 (9%) were lab-confirmed. And 91% of suspected cases were in children younger than five years. 

February 7, 2022 - Confirmed measles cases in Fairfax Health District associated with an unvaccinated individual with recent international travel.

February 5, 2022 - The early warning, alert, and response network (EWARN) detected increased measles cases in the Albad district in northwest Syria, and the measles outbreak spread to other areas. An outbreak response immunization campaign was conducted. A total of 47,061 children were vaccinated (72% coverage).

February 1, 2022 - The U.K. Health Security Agency announced that one in ten eligible children under five in England haven't had the MMR vaccine or are only partially vaccinated.

January 27, 2022 - The Lancet published an article that concluded: Disrupted vaccination activities during the pandemic increase the potential for another resurgence of measles shortly, and practical, timely catch-up vaccination campaigns, firm commitment and leadership, and sufficient resources will be required to mitigate this threat.

Measles Overview

Measles is a very contagious disease caused by a virus. It spreads through the air when an infected person coughs or sneezes. The measles virus can stay in the air for up to 2 hours after an infected person was there. So you can get infected by simply being in a room where an infected person once was. It is so contagious that if one person has it, up to 90% of the people close to them will also become infected if they are not protected.

Clinical Trials

No clinical trials found